ArticlePLOS global public health2024

Prevalence, treatment, and outcomes of hepatitis C in an MDR/RR-TB trial cohort.

Jocelyn Jansen van Vuuren et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.